Kbio Inc.
Overview
Kbio Inc. is a biotechnology company based in the United Kingdom focusing on the development of innovative therapies in oncology and rare diseases. The company is committed to advancing the scientific understanding of these therapeutic areas to bring new treatment options to patients.
Therapeutic areas
API / Drug Master Files
Kbio Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- EV68-228-NActive2023-12-15
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Kbio Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.